However, there were no differences in the gene expression of aldehyde dehydrogenase 1A2 (ALDH1A2) related to ALDH activity (one of the markers for CSCs including prostate cancer [17]) between CSCs and non-CSCs that are used in this study (Figure 3A and Tables S1– S2). This evidence concerns the gene LDHA and prostate carcinoma.